Kelly Gold insider trades
Open-market stock purchases and sales by Kelly Gold, Director at X4 Pharmaceuticals, Inc, from SEC Form 4 filings since Apr 1, 2025.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +130%.
Open-market stock purchases and sales by Kelly Gold, Director at X4 Pharmaceuticals, Inc, from SEC Form 4 filings since Apr 1, 2025.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +130%.